Creating drugs can be complicated and expensive, but BYU researchers have taken a major step toward improving the process for at least one important cancer drug.
Morris J. Robins, the J. Rex Goates Professor of Chemistry, led BYU’s efforts to devise a more effective way of synthesizing cladribine, a drug proven effective against certain types of cancer, including hairy-cell leukemia. In addition, an oral version of the drug is currently undergoing testing as a possible treatment for multiple sclerosis.
Robins is a world leader in nucleoside chemistry, and his past research and discoveries have contributed to the fight against AIDS and hepatitis B.
Read more at more.byu.edu/cladribine